Loading...
Images of Vicken H. Karageozian
(0 from 0 )News
Vicken Karageozian, MD, Named President and Chief Medical Officer of...
eyewire.news
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.
Investigational drug Luminate targets integrin receptors |...
www.ophthalmologytimes.com
Anti-integrin therapy is a promising new approach in the treatment of vitreoretinal disease. The first drug in this class, Allegro Ophthalmics’ Luminate, is in...
Review of Optometry - Optometric Retina Society e-newsletter - March...
www.reviewofoptometry.com
... potentially bringing this new category of treatment forward to help DME patients,” says Vicken Karageozian, MD, Chief Technical Officer, Allegro Ophthalmics, ...
sorted by relevance / date